You can also view and print our Participant Information Sheet as a PDF.
These include In 2023, Deanfield and his research team published research findings that found semaglutide the active ingredient in GLP-1 medications Wegovy and Ozempic could potentially reduce a persons risk for heart attack, stroke, and major cardiac events by 20%
Here's the science bit: drugs like Ozempic, WeGovy and Mounjaro work as GLP-1 agonists - essentially, they mimic the effects of our natural GLP-1 production, meaning they can help treat obesity and conditions such as diabetes, and insulin sensitivities such as polycystic ovarian syndrome (PCOS)
Before drawing any medication, pull the syringe plunger back to draw in a volume of air equal to the volume of medication you plan to withdraw
Es un premio a los pacientes que han permitido que esto sea una realidad y los pacientes del futuro tengan estos tratamientos